Drug discovery and development company Evotec SE has linked up with the younger German biotech, Secarna Pharmaceuticals GmbH, to form a long-term strategic partnership in the area of novel antisense oligonucleotide therapeutics, across targets and indications.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?